The clearest thing to know: butter raises LDL cholesterol compared to olive oil, and at typical food amounts it doesn't shift how long people live. Most of the win here is mental β the slice of buttered toast stops carrying a guilt it never earned, and you stop treating saturated fat as one thing. The catch is that olive oil still has the better heart-outcome trial record, so if your LDL is already on a doctor's worry list, butter is for flavour, not the cooking medium.
Butter is roughly eighty percent milk fat, with a small amount of water and a sliver of milk solids β proteins, calcium, traces of lactose. About sixty-three percent of that fat is saturated, the rest is mostly the same monounsaturated fat that's in olive oil, plus a small fraction of short-chain fats unique to dairy. What sets it apart from ghee (clarified butter, milk solids removed) and from rendered animal fats like tallow is the milk part: the membrane that wraps each tiny fat droplet, the calcium and protein that ride along, the fat-soluble vitamins A, D, E, and K2 that you only get from fats that came from something alive.
The reason this matters is the food matrix β the structure the fat arrives in. Saturated fat eaten as butter, eaten as cheese, eaten as a hamburger, and eaten as a spoonful of coconut oil all do different things in the body, even though the lab report says they're the same grams of the same fatty acids. Cheese, which usually has more saturated fat per gram than butter, raises LDL cholesterol substantially less de Goede et al. 2015, Brassard et al. 2017 β the calcium and milk proteins in cheese bind some of the fat in the gut and carry it out the other end. Butter has lost most of that calcium and protein in the churning, so it sits closer to "just the fat" than cheese does β but it still has the membrane and the milk-solid traces, which is why it doesn't behave like tallow either.
What the evidence actually says
The cleanest single answer to does butter shorten your life is the 2016 meta-analysis that pooled nine long-term studies tracking about 636,000 people. The result was unglamorous: roughly neutral. Each tablespoon-a-day of butter was associated with a one percent relative increase in dying from any cause, no significant change in cardiovascular disease, and a small drop in incident type 2 diabetes Pimpin et al. 2016. That's the number the lay press grabbed and called "butter is back." The honest reading is "butter is fine in normal food amounts" β closer to a shrug than a vindication.
The lipid story is more settled. Every time researchers feed people 40 to 50 grams a day of butter and compare them to people eating the same amount of olive oil, LDL cholesterol goes up Engel and Tholstrup 2015, Khaw et al. 2018. HDL also goes up, which is the part nobody mentions, but the modern picture is that HDL going up doesn't reliably translate into fewer heart attacks β drug trials that pushed HDL up have repeatedly failed to reduce events. So the net signal on lipids, compared to olive oil, is mildly worse on butter. Compared to a habitual Western diet, butter often looks neutral or even slightly favourable because of the HDL bump, but the comparison that matters for the heart is butter versus the better fats, not butter versus the average plate.
What most takes get wrong
The "butter is back" headline that came out of the 2016 meta-analysis was a misread of a null result. Roughly neutral is not vindicated β and certainly not better than olive oil. If you've been told butter is now considered heart-healthy, you've been told a louder version of what the data actually says.
The mirror-image mistake is treating butter as interchangeable with ghee, tallow, lard, or coconut oil because they're all "saturated animal fats." They're not the same. Ghee has had the milk solids removed; tallow and lard never had them; coconut oil isn't even from an animal. Butter is the only one of these that carries the dairy package β the membrane on each fat droplet, the leftover calcium and protein from the cream β and that package is most of why the cohort numbers come out the way they do. Lumping it in with the others is the same category error as saturated fat from cheese is the same as saturated fat from a hot dog. The grams match; the food doesn't.
The third one is the HDL victory lap. Butter does raise HDL cholesterol β yes, the "good" one. Decades of newer evidence have pulled the rug out from under HDL as a causal target: drugs that raise it haven't reduced heart attacks, and the genetics tells the same story. Butter's HDL bump is real but, on current evidence, not the trump card it's sometimes played as.
If not butter, then what
Extra-virgin olive oil is the default fat with the best record on hard heart-disease outcomes β the Mediterranean-diet trials are where the biggest reductions in actual heart attacks come from, not from any specific saturated-fat-cutting protocol. For everyday sautΓ©ing, salad, and most cooking where flavour isn't the whole point, olive oil is the first-line answer for anyone whose doctor watches their cholesterol.
Seed oils β canola, sunflower, soybean β are where the polyunsaturated-fat trials get their wins; replacing saturated fat with these specifically does seem to drop heart events Mozaffarian, Micha, and Wallace 2010. The internet's panic about "seed oils" is largely vibes, not evidence. Coconut oil, often sold as a heart-healthy alternative to butter, actually raises LDL more than butter does at the same gram amount Khaw et al. 2018 β the marketing got out ahead of the data.
Ghee β clarified butter β is butter with the water and milk solids cooked off. It tolerates higher heat (no milk solids to scorch), but in terms of what it does to your cholesterol numbers, it's basically butter without the dairy package. If anything the missing milk solids make it slightly worse, not better.
How to actually use it
Butter as a flavour ingredient β a knob in the pan with eggs, finishing a sauce, on toast β sits inside the consumption range of every study cited above, with no measurable cost. Butter as a primary cooking medium for someone eating a lot of meat and cheese is a different question, because it stacks the saturated fat. The cardiology baseline of about 20 to 40 grams a day of butter is the rough ceiling in a typical 2000-calorie day before saturated fat as a percentage of calories crosses the AHA's line β and that ceiling already assumes butter is your only major source.
The grass-fed and cultured premium brands are mostly culinary differences, not cardiovascular ones β the fatty-acid profile shifts a little, the price doubles, the studies don't break out which kind of butter people ate. Buy what tastes better to you; if that's the cheapest stick in the supermarket, that's fine.
When the easy answer changes
The "neutral at normal amounts" finding from the cohort data is a general adult finding. It doesn't survive contact with three specific situations, and if any of these describe you, the cooking-default tilts back toward olive oil.
For most general-adult readers without those flags, the worry is misplaced and the simpler answer holds: butter is one of several fats in the rotation, used where it earns its place.
What changes once you stop fearing it
Inside a week, the small thing: weeknight cooking starts tasting like something again. The pan you sautΓ© onions in tonight gets a piece of butter, the eggs Saturday morning are scrambled in it, the dinner you used to flatten with cooking spray becomes a meal you'd serve a friend. The flavour was always available; the guilt was the part you put down.
Within months, the second-order shift: you stop reading "saturated fat" on a nutrition label as a single thing to fear, because you've internalised that the food it's in is what matters. Cheese on the cracker stops being a guilty pleasure. Yogurt stops being a thing you pick the lowest-fat version of. The food-matrix idea generalises β sugar in fruit isn't the same as sugar in soda, salt in olives isn't the same as salt in a bouillon cube β and you start eating like a person, not like a label.
The longer payoff is harder to put a number on but real: you've watched a 40-year nutritional dogma quietly retreat in the actual literature, while the guidance lagged a decade behind. Next time a food gets demonised on weak grounds, you wait. That's not nothing.
Related questions worth their own look: extra-virgin olive oil (the fat with the strongest record on actual heart attacks, and the better default for most cooking); ghee (overlapping but distinct β different smoke point, no milk solids, traditional use); seed oils (where the internet panic and the trial evidence point in opposite directions); ApoB testing (the lipid number more strongly tied to heart disease than LDL alone, and the one your dietary fat choices actually move). The bigger frame is the food matrix β once it clicks for butter, it changes how you read everything else on a label.
Substance + claimed effects
The substance is whole dairy butter β cream churned until the fat globules invert and separate from buttermilk, then washed and worked into a solid. Composition is roughly 80% milk fat, 16-17% water, and 1-2% milk solids (proteins, lactose, minerals, salt if salted). The fatty-acid profile is ~63% saturated, ~26% monounsaturated, ~4% polyunsaturated, plus 3-4% short-chain (butyric, caproic) and medium-chain fatty acids unique to ruminant milk. Distinct from ghee (clarified butter, milk solids and water removed) and from rendered animal fats like tallow or lard (no milk components at all). Butter retains the milk-fat-globule membrane (MFGM) β a phospholipid-rich layer that wraps each fat droplet and survives churning. The dairy matrix is intact: fat, MFGM, milk proteins, calcium, fat-soluble vitamins A, D, E, K2, all delivered together in food.
Claimed effects this entry covers: effect on LDL and HDL cholesterol; effect on satiety and blood pressure; cardiovascular and total-mortality association in cohort and trial data; comparison to plant oils (extra-virgin olive, seed oils); the saturated-fat-and-disease question filtered through the modern food-matrix lens; the contribution of butyrate, MFGM, and the fat-soluble vitamins inside an intact dairy matrix.
Evidence by addressing question
mechanism
Three mechanisms account for nearly all of butter's measurable physiology: the saturated-fatty-acid load on the liver, the food-matrix delivery that the SFAs arrive in, and a small contribution from the bioactives unique to dairy fat.
Saturated fatty acids β particularly lauric (C12), myristic (C14), and palmitic (C16) β upregulate hepatic LDL receptor downregulation pathways and increase serum LDL-cholesterol concentrations relative to monounsaturated or polyunsaturated fat. The lipid change is consistent and dose-dependent: substituting butter for olive oil at 40 g/day in healthy adults raises LDL-C by ~7% over six weeks Engel and Tholstrup 2015. The same swap raises HDL-C by roughly 7% as well β the often-overlooked second arm β yielding a smaller change in the LDL:HDL ratio than the LDL number alone suggests Khaw et al. 2018.
The food-matrix effect blunts that lipid response when SFAs are delivered in an intact dairy structure. Cheese β same fatty-acid profile as butter, sometimes more SFA per gram β raises LDL substantially less than equivalent SFAs from butter; the calcium-fat complex hypothesis is the leading explanation: calcium and milk proteins bind fatty acids in the gut, increasing fecal fat excretion and reducing absorption de Goede et al. 2015, Brassard et al. 2017. Butter has lost most of the calcium and protein that cheese retains; its matrix is more like rendered fat than like the dairy whole. This is why "saturated fat from butter" and "saturated fat from cheese or yogurt" are not interchangeable in modern dairy-matrix analyses.
The milk-fat-globule membrane carries phospholipids (sphingomyelin, phosphatidylcholine), cholesterol, and proteins. MFGM-enriched feeding lowers LDL relative to MFGM-stripped fat with the same triglyceride profile in animal and small-human studies, suggesting butter's lipid effect is mitigated relative to a hypothetical SFA-only oil. The short-chain fatty acid butyrate (~3% of butter fat) is also produced colonically from dietary fiber; the small bolus arriving via butter is dwarfed by the colonic source, so framing butter as a "butyrate supplement" overstates the dose. Fat-soluble vitamins A, D, E, and K2 ride along; intake is real but modest unless butter is a primary fat.
evidence
The butter-specific evidence is narrower than the broader saturated-fat literature. The cleanest synthesis is Pimpin et al. 2016, a systematic review and meta-analysis of nine cohort studies (n ~636,000, ~28,000 deaths). Each daily 14-g serving of butter was associated with a 1% relative increase in all-cause mortality (RR 1.01, 95% CI 1.00-1.03), no significant association with cardiovascular disease (RR 1.00, 0.98-1.02), and a small inverse association with incident type 2 diabetes (RR 0.96, 0.93-0.99). Read straight: butter consumption at typical intake levels has a small or null association with hard endpoints β neither the villain of the 1980s diet-heart era nor the hero of contemporary contrarian framing.
The broader saturated-fat-and-CVD literature is where most of the inference flows. de Souza et al. 2015 (BMJ systematic review) found no significant association between SFA intake and all-cause mortality, CVD mortality, stroke, or type 2 diabetes β though SFA intake was modestly associated with coronary heart disease. Hooper et al. 2020, the Cochrane review, found that reducing SFA modestly reduces combined cardiovascular events (RR 0.83, 0.76-0.90) when SFA is replaced specifically by polyunsaturated fat; the effect on mortality is weaker. The PURE study Dehghan et al. 2017, a 135,000-participant prospective cohort across 18 countries, found higher SFA intake associated with lower stroke risk and no significant CVD-mortality association; higher carbohydrate intake associated with higher mortality. This dataset shifted the field.
RCT-level data on butter is sparse but consistent. Khaw et al. 2018 randomised 96 healthy adults to 50 g/day coconut oil, olive oil, or butter for four weeks. Butter raised LDL-C by ~16 mg/dL vs olive oil; HDL-C also rose; non-HDL change was the cleaner risk signal and was significantly higher on butter. Engel and Tholstrup 2015 ran a similar substitution at 40 g/day for six weeks and reported the same pattern β LDL up vs olive oil, HDL up vs habitual diet.
The dairy-matrix layer is captured in Soedamah-Muthu et al. 2011's dose-response meta-analysis and Drouin-Chartier et al. 2016's systematic review: total dairy consumption is neutral or slightly protective for CVD and all-cause mortality, with fermented dairy (cheese, yogurt) reading more favourably than non-fermented; Brassard et al. 2017 directly compared SFA-matched butter vs cheese feeding in a 4-arm RCT and confirmed cheese raises LDL less than butter at equal SFA dose. Astrup et al. 2020's JACC reassessment is the umbrella synthesis: SFA as a single nutrient is the wrong unit; the food carrying it matters.
Practice / clinical consensus: Sacks et al. 2017's AHA Presidential Advisory holds the conservative position β limit SFA to <6% of calories, replace with PUFA β and continues to recommend butter be limited. The 2020-2025 Dietary Guidelines for Americans concur. Astrup et al. 2020 represents a credentialled minority view (cardiology and nutrition researchers) that whole-dairy food-matrix recommendations should supersede the SFA-nutrient frame. The field is in genuine paradigm flux β high evidence on lipid effects, high controversy on the clinical translation.
misconceptions
Three common errors. First, the "Butter is back" framing in the lay press substantially overstates Pimpin 2016 β the meta-analysis showed neutrality, not benefit; presenting it as vindication of any-quantity butter consumption is selective reading. Second, conflating butter with ghee and tallow as "saturated animal fats" misses the dairy-matrix point β butter still carries MFGM and milk solids that ghee and tallow do not. Third, treating butter's HDL-raising effect as cardiovascular protection ignores the modern picture: HDL-C is a poor causal target, drug-induced HDL increases have failed to reduce CVD events, and ApoB / non-HDL-C are the better risk numbers. Butter's HDL bump is real but not, on current evidence, clinically meaningful.
alternatives
Extra-virgin olive oil has the strongest CVD-outcome trial backing (PREDIMED; ~30% relative risk reduction in major cardiovascular events in the high-risk Mediterranean-diet arm). For sautΓ©ing, neutral cooking, and uses where flavour is incidental, olive oil is the default first-line fat for cardiovascular-risk-aware readers. Seed oils (canola, sunflower, soybean) provide PUFA and have the most consistent RCT-level support for replacement of SFA, per Mozaffarian, Micha, and Wallace 2010. Ghee β clarified butter β removes milk solids and water, raising the smoke point and concentrating SFA; lipid effects are similar to butter, with slightly different uses. Coconut oil raises LDL more than butter per gram of fat at equal dose Khaw et al. 2018; framing it as "heart-healthy" is unsupported. Tallow and lard sit in an under-studied middle.
protocol
No dose is "required" β butter is a food, not a supplement. Typical use as a table and cooking fat (10-20 g/day, ~1-2 tablespoons) sits within the consumption range of every cited cohort and is associated with neutral mortality. The standard cardiology limit (SFA <10% of calories, AHA <6%) translates to about 20-40 g/day of butter as a hard ceiling in a typical 2000-kcal diet, with no other major SFA sources. Smoke point ~150Β°C / 300Β°F (butter), ~250Β°C / 480Β°F (ghee); for high-heat searing, ghee or a neutral oil avoids the milk-solid browning that gives butter its flavour but can scorch.
contraindications
Established atherosclerotic CVD, familial hypercholesterolemia, or LDL-C above clinical thresholds: AHA-style SFA limits apply more firmly. Butter as a primary cooking fat in these populations conflicts with secondary-prevention LDL-lowering targets. The literature here is unambiguous β for a person with documented CHD on a statin, lowering SFA further is part of the standard package. The general-population picture (small to neutral mortality effect) does not extrapolate to people with established disease, where lipid trajectory directly drives event risk.
audience
Cardiovascular-risk-aware readers (family history, high LDL, mid-life ApoB testing) benefit from a more cautious framing β the default fat is olive oil; butter is a flavour ingredient, not a cooking medium. The general-adult reader with no specific cardiometabolic risk can use butter as one of several rotating fats without measurable harm at typical intake. The ketogenic and carnivore communities use butter at higher doses (50-100 g/day) where SFA constitutes 20-30% of calories β well above the boundary of any cited safety dataset; the LDL elevations in these populations are real and substantial. The catalogue's reader is the moderate cook, not the extreme dieter.
stakes
The realistic stakes are modest in both directions. Within the moderate-intake range, neither aggressive avoidance nor aggressive consumption of butter is likely to shift cardiovascular outcomes meaningfully β the dietary fat that ends up in the seat butter vacates (refined seed oil vs olive oil vs sugar) matters more than the butter itself. The stakes section's job here is felt-experience honesty: a reader who has been fearing butter for 30 years gets back the small daily pleasure with no real cost; a reader who has been consuming heroic doses on the assumption it's "free" learns the LDL data.
payoff
Modest. Fat-soluble vitamin intake gets a small bump if butter replaces a vitamin-light fat. The satiety value of fat in a meal is real and well-documented for fat as a macronutrient; whether butter is specifically more satiating than olive oil is unsettled. The honest payoff is psychological: removal of a misplaced fear, restoration of a small flavour element of cooking, and the matrix-effect realisation that scales to broader food choices (cheese and yogurt are not just "saturated fat in disguise").
out-of-scope
Margarine and butter substitutes (separate substance, separate evidence base β historical trans-fat era + modern blends). Ghee specifically (overlapping but distinct substance β no milk solids, different culinary use, traditional preparation considerations). Cream and full-fat dairy as ingredient. The broader ApoB / lipid-management framework. Plant-oil-specific evidence (olive oil, seed oil controversies).
The credibility range
The optimist case. Butter is rehabilitated. Cohort meta-analysis shows neutral or slightly favourable mortality association Pimpin et al. 2016; the large PURE prospective cohort found higher SFA intake associated with lower stroke and no CVD-mortality excess Dehghan et al. 2017; the dairy-matrix literature shows that whole-dairy SFA behaves differently from rendered-fat SFA Astrup et al. 2020, Brassard et al. 2017. The HDL-raising effect is real. Butter delivers fat-soluble vitamins, butyrate precursors, MFGM phospholipids, and culinary value the substitutes don't match. The 40-year sat-fat panic was over-extrapolated from a thin and politicised evidence base, and modern reassessment supports moderate butter consumption as compatible with cardiovascular health.
The skeptic case. The lipid signal is unambiguous: in every controlled feeding study, butter raises LDL-C and ApoB compared with olive oil or polyunsaturated alternatives Engel and Tholstrup 2015, Khaw et al. 2018. Mendelian-randomisation and pharmacological evidence on LDL is settled β lifetime LDL exposure causes atherosclerotic disease, full stop. RCTs replacing SFA with PUFA reduce CVD events Mozaffarian, Micha, and Wallace 2010, Hooper et al. 2020. The AHA, Dietary Guidelines, and ESC all maintain SFA limits Sacks et al. 2017. The "butter is back" narrative was driven partly by industry and partly by media misreading null cohort results as positive ones. Butter raises a causal cardiovascular risk factor; that fact does not vanish because the population-level mortality signal is small.
The author's call. The honest landing is in the middle: butter is not a poison and not a health food. At typical food-quantity intake (a tablespoon a day, a flavour ingredient rather than a cooking medium), the cohort evidence shows no measurable harm and the lipid effects are modest. The dairy-matrix point is real and meaningful β butter is not interchangeable with rendered animal fat or with a hypothetical pure-SFA oil. But the lipid effect compared to olive oil is also real and meaningful; for a reader with cardiovascular risk on the table, olive oil is the better default. The article should land roughly where Astrup 2020 lands: re-licence moderate butter consumption, do not promote heroic doses, and frame the substitution question (what does butter replace?) as more important than the absolute butter quantity. Controversy stays high because the AHA and the dairy-matrix camp have not converged.
Stakeholder + incentive map
- Dairy industry β clear commercial interest in butter rehabilitation. Funded a meaningful share of the dairy-matrix research, though independent academic groups (Mozaffarian's at Tufts, Astrup's in Copenhagen, the Quebec dairy-matrix cluster) have replicated key findings.
- Seed-oil and margarine industry β commercial counter-interest. Pushed the original 1970s-80s saturated-fat panic in concert with the American Heart Association.
- AHA / Dietary Guidelines / cardiology guidelines bodies β institutional inertia. Reversing a 40-year recommendation is reputationally expensive; the conservative position holds even as the evidence base shifts.
- Low-carb / ketogenic / carnivore communities β community incentive to position butter as health-positive at heroic doses, well beyond cited evidence.
- Mediterranean-diet researchers β career investment in the olive-oil-first framework; PREDIMED is their flagship.
- Lipidologists / preventive cardiologists β emphasise the LDL / ApoB causal chain regardless of food source.
Population variability
Lipid response to dietary SFA is heterogeneous. ApoE genotype, baseline LDL receptor activity, statin status, and BMI all modulate the LDL change. Roughly a third of adults are "hyper-responders" β large LDL swings in response to dietary SFA change β and roughly a third are "non-responders." Familial hypercholesterolemia patients are the extreme high-responder population and require dietary SFA limitation as part of standard care. Cardiovascular outcome data is dominated by middle-aged adults; pediatric, late-elderly, and chronic-disease populations are under-represented in the butter-specific cohorts. Effect modification by overall diet pattern is large β butter inside a Mediterranean dietary pattern is studied differently from butter inside a Western pattern.
Knowledge gaps
No long-duration RCT with butter as the intervention and hard cardiovascular endpoints exists or is likely ever to exist β the trial would be impractical and expensive. The dairy-matrix mechanism is partially characterised (calcium-fat complex, MFGM, fermentation byproducts in cheese and yogurt) but the per-component contribution is not nailed down. Butter's specific vs general dairy-matrix effect is under-quantified β most matrix studies use cheese, not butter, as the comparator. The HDL-raising effect's clinical meaning is unsettled given the broader collapse of HDL-as-causal hypotheses. Whether grass-fed vs grain-fed butter differs meaningfully (fatty-acid profile shifts, CLA content) at typical doses is plausible but under-evidenced; the cited literature does not stratify.
Brief alignment. The input description named LDL/HDL effects, satiety, blood pressure, milk-solid / saturated-fat / butyrate / fat-soluble-vitamin content within an intact dairy matrix, and the cardiovascular comparison to plant oils. Coverage in the article: LDL/HDL effects covered in evidence and misconceptions; satiety touched lightly in highlights (the fat-in-a-meal effect is well-documented at the macronutrient level but not butter-specifically distinguishable from olive oil in the trial literature, so the article does not overstate it); the dairy matrix β milk solids, saturated fat, fat-soluble vitamins, MFGM β is the spine of mechanism; plant-oil comparison anchors alternatives; the AHA-vs-reassessment paradigm split runs through evidence, misconceptions, and contraindications/audience.
Two named brief items deliberately under-treated in the body, both honestly.
- Butyrate. Named in the brief as a dairy-matrix component. Research dossier treats it; the article does not give it dedicated paragraphs. Reason: the dose of butyric acid arriving via a tablespoon of butter is dwarfed by the colonic production from dietary fibre, so making butyrate a load-bearing reason-to-eat-butter would overstate the evidence. The fat-soluble vitamins and MFGM carry the dairy-matrix point honestly without it.
- Blood pressure. Named in the brief. No consistent BP signal attributable to butter at typical intake in the cited literature. A section saying so would be padding; the article does not invent one. Research dossier notes the absence.
Action / cadence call. Chose know + once over do + daily. The entry's value is updated mental model β readers walk away with a better category for "saturated fat" and a defensible cooking-default β not a prescribed habit. The catalogue's do entries are interventions someone takes up; this is literacy that licences an existing food without prescribing it.
Score difficulties.
- longevity at 1, not 0 or 2: Pimpin 2016 was a hair on the wrong side of neutral (RR 1.01) but the confidence interval crosses 1, and the diabetes signal was small-inverse. A score of 0 would imply "no effect at all," which is overstated β butter does interact with lipid biology. A 2 would imply a real if small mortality contribution, which the meta-analysis doesn't support. 1 β "marginal contribution" β is the honest read.
- controversy at 4: came close to 5. The AHA position and the dairy-matrix reassessment camp don't share a methodology, and the convergence-point is years out. But the lipid effects themselves are not contested β only the clinical translation. 4 captures the foundational disagreement without claiming the field is in open warfare.
- evidence at 4: the lipid-endpoint trials are abundant and consistent; the hard-endpoint translation is where the field disagrees, which pulls the score off a 5 but not below 4. Two-plus rigorous syntheses (Pimpin 2016, Hooper 2020 Cochrane) plus multiple feeding RCTs (Engel 2015, Khaw 2018, Brassard 2017) clear the 4 bar.
- beauty_cumulative at 0, not 1: considered crediting a fat-soluble-vitamin-A pathway to skin/hair, but the dose from typical butter intake is small and the catalogue's beauty-cumulative anchor would require a real attributable effect. Honest call is 0.
Contraindication. Used cardiac-condition for the established-CHD / familial-hypercholesterolemia case. Did not use uncontrolled-hypertension because the BP signal for butter specifically is not strong enough to warrant blocking the entry from those readers.
Future-link candidates. Entries this should cross-reference once they exist: extra-virgin olive oil, ghee, ApoB testing, seed oils, cheese, dietary saturated fat (as a concept). The related field is empty at draft; populate once those entries land.
Separate-entry candidates. The food matrix idea may warrant its own meta-entry on the "how to read nutrition labels" axis β it generalises beyond dairy fat. The seed-oil controversy deserves its own dedicated treatment; this entry only addresses it inline as the closest plant-oil alternative.
Stance. Landed roughly where Astrup 2020 lands β re-licence moderate butter consumption, do not promote heroic doses, frame the substitution question (what does butter replace?) as the load-bearing one. Held the line on not turning the article into "butter is health food," which the contrarian-podcast version of this entry would do.
Butter
Cheap. A tablespoon-a-day habit runs about twenty to forty dollars a year.
Multiple large meta-analyses and controlled feeding trials β the lipid numbers are nailed down; the field still argues about what they mean for heart attacks.
Fat in a meal is filling, and butter brings along vitamins A, D, E, and K2 that water-cooked food can't deliver.
A meta-analysis of 636,000 people found butter near-neutral for lifespan at normal food amounts β neither the villain nor the hero the headlines made it.